INJECTION SITE JOINT INFLAMMATION

This adverse event was reported 12 times

These drugs are most commonly taken by patients reporting INJECTION SITE JOINT INFLAMMATION:

# Drug Count
0 INTERFERON BETA-1A 2
1 AMITRIPTYLINE HYDROCHLORIDE 1
2 ARIPIPRAZOLE 1
3 CLOZAPINE 1
4 CRIZANLIZUMAB 1
5 EPINEPHRINE 1
6 FEBUXOSTAT 1
7 FEBUXOSTAT TABLETS 40 MG 1
8 FEBUXOSTAT TABLETS 80 MG 1
9 FOLIC ACID 1
See all common drugs associated with INJECTION SITE JOINT INFLAMMATION

INJECTION SITE JOINT INFLAMMATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CRIZANLIZUMAB 1 0.0007
1 FEBUXOSTAT TABLETS 40 MG 1 0.0001
2 FEBUXOSTAT 1 0.0001
3 AMITRIPTYLINE HYDROCHLORIDE 1 0.0001
4 LITHIUM 1 0.0000
5 EPINEPHRINE 1 0.0000
6 IRON 1 0.0000
7 VITAMIN C 1 0.0000
8 INTERFERON BETA-1A 2 0.0000
9 LEFLUNOMIDE 1 0.0000
See all drugs enriched for association with INJECTION SITE JOINT INFLAMMATION

INJECTION SITE JOINT INFLAMMATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Selectin Blocker [EPC] 1 0.0007
1 Catecholamine [EPC] 1 0.0000
2 Interferon beta [EPC] 2 0.0000
3 Antirheumatic Agent [EPC] 1 0.0000
4 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
5 Vitamin D [EPC] 1 0.0000
6 Vitamin B12 [EPC] 1 0.0000
7 Vitamin C [EPC] 1 0.0000
8 Atypical Antipsychotic [EPC] 1 0.0000
9 Proton Pump Inhibitor [EPC] 1 0.0000
See all drug classes enriched for association with INJECTION SITE JOINT INFLAMMATION